These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1707985)

  • 21. Binding behaviour of antibodies reacting specifically with an immunodominant region of the transmembrane protein gp41 of HIV-1.
    Döpel SH; Porstmann T; Grunow R; Henklein P; Pas P; von Baehr R
    J Virol Methods; 1990 May; 28(2):189-98. PubMed ID: 1695222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection.
    Eberle J; Loussert-Ajaka I; Brust S; Zekeng L; Hauser PH; Kaptue L; Knapp S; Damond F; Saragosti S; Simon F; Gürtler LG
    J Virol Methods; 1997 Aug; 67(1):85-91. PubMed ID: 9274821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.
    Ugen KE; Srikantan V; Goedert JJ; Nelson RP; Williams WV; Weiner DB
    J Infect Dis; 1997 Jan; 175(1):63-9. PubMed ID: 8985197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
    Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.
    Bugge TH; Lindhardt BO; Hansen LL; Kusk P; Hulgaard E; Holmbäck K; Klasse PJ; Zeuthen J; Ulrich K
    J Virol; 1990 Sep; 64(9):4123-9. PubMed ID: 1696634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.
    Dorn J; Masciotra S; Yang C; Downing R; Biryahwaho B; Mastro TD; Nkengasong J; Pieniazek D; Rayfield MA; Hu DJ; Lal RB
    J Clin Microbiol; 2000 Feb; 38(2):773-80. PubMed ID: 10655384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus.
    Gairin JE; Madaule P; Traincard F; Barrès E; Rossier J
    FEMS Microbiol Immunol; 1991 Apr; 3(2):109-19. PubMed ID: 1863470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1.
    Muster T; Steindl F; Purtscher M; Trkola A; Klima A; Himmler G; Rüker F; Katinger H
    J Virol; 1993 Nov; 67(11):6642-7. PubMed ID: 7692082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic properties of phage displayed peptides comprising disulfide-bonded loop of the immunodominant region of HIV-1 gp41.
    Cano A; Viveros M; Acero G; Govezensky T; Munguia ME; Gonzalez E; Soto L; Gevorkian G; Manoutcharian K
    Immunol Lett; 2004 Sep; 95(2):207-12. PubMed ID: 15388262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential IgG subclass responses to epitopes in transmembrane protein of HIV-1.
    Klasse PJ; Blomberg J; Pipkorn R
    Viral Immunol; 1990; 3(2):89-98. PubMed ID: 1694431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the fine structure of the antigenic determinants of the transmembrane protein in the HIV coat with chemically modified synthetic peptides.
    Andreev SM; Meshcheryakova DB; Vafina MG; Az'muko AA; Sidorova MV; Khaitov RM
    Biomed Sci; 1991; 2(3):271-8. PubMed ID: 1751760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antibody response to the HIV-1 specific "out" (vpu) protein: identification of an immunodominant epitope and correlation of antibody detectability to clinical stages.
    Schneider T; Hildebrandt P; Rönspeck W; Weigelt W; Pauli G
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):943-50. PubMed ID: 1697179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of the diagnostic value of recombinant antigens and synthetic peptides that mimic the immunogenic epitopes of the envelop protein gp41 in the enzyme immunodetection of HIV-1 antibodies].
    Baranova EN; Puzyrev VF; Van'kova OE; Pimenov VK; Burkov AN; Obriadina AP; Ulanova TI
    Vopr Virusol; 2006; 51(3):46-8. PubMed ID: 16826757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
    Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS
    J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection.
    Parekh BS; Pau CP; Kennedy MS; Dobbs TL; McDougal JS
    AIDS Res Hum Retroviruses; 2001 Jan; 17(2):137-46. PubMed ID: 11177393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
    Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
    Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
    Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
    Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and characterization of human monoclonal antibodies against core protein p25 and transmembrane glycoprotein gp41 of HIV-1.
    Prigent S; Goossens D; Clerget-Raslain B; Bahraoui E; Roussel M; Tsikas G; Laurent A; Montagnier L; Salmon C; Gluckman JC
    AIDS; 1990 Jan; 4(1):11-9. PubMed ID: 2156527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.